KCM
LFCR icon

Kennedy Capital Management’s Lifecore Biomedical LFCR Stock Holding History

Kennedy Capital Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-704,722
Closed -$7.82M – 619
2021
Q4 		$7.82M Sell
704,722
-92,013
-12% -$893K 0.16% 230
2021
Q3 		$7.35M Sell
796,735
-88,068
-10% -$958K 0.16% 233
2021
Q2 		$9.95M Sell
884,803
-234,055
-21% -$2.7M 0.21% 162
2021
Q1 		$11.9M Buy
1,118,858
+47,491
+4% +$534K 0.24% 136
2020
Q4 		$11.6M Buy
1,071,367
+615,069
+135% +$6.35M 0.26% 115
2020
Q3 		$4.43M Buy
+456,298
New +$4.35M 0.13% 310
2019
Q2 		– Sell
-203,457
Closed -$2.5M – 714
2019
Q1 		$2.5M Buy
203,457
+11,894
+6% +$145K 0.06% 499
2018
Q4 		$2.27M Buy
191,563
+37,195
+24% +$511K 0.06% 517
2018
Q3 		$2.22M Sell
154,368
-6,931
-4% -$95.8K 0.04% 570
2018
Q2 		$2.4M Sell
161,299
-31,682
-16% -$440K 0.04% 577
2018
Q1 		$2.52M Buy
192,981
+81,095
+72% +$1.07M 0.05% 565
2017
Q4 		$1.41M Buy
+111,886
New +$1.41M 0.03% 644
2014
Q3 		– Sell
-30,524
Closed -$381K – 770
2014
Q2 		$381K Sell
30,524
-36,349
-54% -$428K 0.01% 707
2014
Q1 		$746K Sell
66,873
-14,053
-17% -$154K 0.01% 668
2013
Q4 		$981K Buy
80,926
+14,548
+22% +$174K 0.02% 645
2013
Q3 		$810K Sell
66,378
-20,129
-23% -$281K 0.02% 664
2013
Q2 		$1.14M Buy
+86,507
New +$1.2M 0.02% 624

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kennedy Capital Management's LFCR Position: Q1 2022 in Review

Kennedy Capital Management sold out of Lifecore Biomedical (LFCR) in Q1 2022, closing a stake of 704,722 shares — an estimated $7.82M sold.

Kennedy Capital Management first reported a position in LFCR in Q2 2013 and held it in 17 quarters. The position peaked at $11.9M in Q1 2021. 97 funds tracked by Wall St. Rank hold LFCR as of Q1 2022.

  • Kennedy Capital Management reported no remaining Lifecore Biomedical position as of Q1 2022 after selling out during the quarter.
  • Kennedy Capital Management sold 704,722 Lifecore Biomedical shares in Q1 2022, an estimated $7.82M.
  • Kennedy Capital Management first reported a position in Lifecore Biomedical in Q2 2013 and held it in 17 quarters.
  • Kennedy Capital Management's Lifecore Biomedical position peaked at $11.9M in Q1 2021.
  • 97 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2022.

Based on Kennedy Capital Management's 13F filing for Q1 2022, filed 16 May 2022.